1-12 of 12
Jiri Mayer, M.D., PhD., Prof.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Fate of Chronic Lymphocytic Leukemia Patients After Failure of Fludarabine, Cyclophosphamide, and Rituximab Regimen

Anna Panovska, MD, Daniel Lysák, MD, Lukas Smolej, M.D., Ph.D., Yvona Brychtova, M.D., Ph.D., Martin Simkovic, MD, Monika Motyckova, M.D., Michaela Lindtnerova, MD, Martin Trbusek, PhD, Jitka Malcikova, Dr, PhD, Sarka Pospisilova, Prof., Jiri Mayer, M.D., PhD., Prof., Michael Doubek, M.D., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 4603.
https://doi.org/10.1182/blood.V120.21.4603.4603
Published: 2012
Journal Articles

Apoptosis in Chronic Myeloid Leukemia Cells Transiently Treated with Imatinib or Dasatinib Is Caused by Residual BCR-ABL Kinase Inhibition

Pavel Simara, PhD., Stanislav Stejskal, MSc., Irena Koutna, PhD., David Potesil, MSc., Lenka Tesarova, PhD., Michaela Potesilova, MSc., Zbynek Zdrahal, Dr., Jiri Mayer, M.D., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 1668.
https://doi.org/10.1182/blood.V120.21.1668.1668
Published: 2012
Journal Articles

Ofatumumab (OFA) in Combination with CHOP for Previously Untreated Follicular Lymphoma: Follow-up Results

Myron S. Czuczman, MD, Georg Hess, Ole Gadeberg, Lars Moeller Pedersen, Per Hansen, David Belada, M.D., Ph.D., Stephanie A. Gregory, MD, Brad Pohlman, MD, Jiri Mayer, M.D., PhD., Prof., Robert Pytlik, Lorenz Trumper, Andreas Viardot, MD, Ira V. Gupta, MD, Thomas S. Lin, MD, PhD, Paul Winter, Nancy Goldstein, Roxanne C. Jewell, PhD, Steen Lisby, MD, DMSc
Journal: Blood
Blood (2012) 120 (21): 1632.
https://doi.org/10.1182/blood.V120.21.1632.1632
Published: 2012
Journal Articles

Microrna-34a As a Marker for Fludarabine Resistance and Impairment of p53-Pathway in Chronic Lymphocytic Leukemia

Marek Mraz, MD, PhD, Katerina Cerna, Veronika Mayerova, Katerina Musilova, Karla Plevova, Sarka Pavlova, PhD, Boris Tichy, Dr., PhD., Michael Doubek, M.D., PhD., Prof., Yvona Brychtova, M.D., Ph.D., Jitka Malcikova, Dr, PhD, Jiri Mayer, M.D., PhD., Prof., Martin Trbusek, PhD, Sarka Pospisilova, Dr, PhD
Journal: Blood
Blood (2012) 120 (21): 3883.
https://doi.org/10.1182/blood.V120.21.3883.3883
Published: 2012
Journal Articles

Sequence Variations in miRNA Genes Are Common and May Affect Their Expression in Patients with Chronic Lymphocytic Leukemia

Jana Kminkova, PharmD., Marek Mraz, MD, PhD, Veronika Navrkalova, MSc., Boris Tichy, Dr., PhD., Jitka Malcikova, Dr., PhD., Karla Plevova, Vladimir Benes, Tobias Rausch, PhD, Yvona Brychtova, M.D., Ph.D., Michael Doubek, M.D., PhD., Prof., Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Dr., PhD, Prof.
Journal: Blood
Blood (2012) 120 (21): 3895.
https://doi.org/10.1182/blood.V120.21.3895.3895
Published: 2012
Journal Articles

Defects of ATM Gene Involving Mutation Lead to Complete Elimination of ATM Function in Chronic Lymphocytic Leukemia

Veronika Navrkalova, MSc., Ludmila Sebejova, Dr., Jana Zemanova, Jana Kminkova, PharmD., Blanka Kubesova, Michael Doubek, Prof., Yvona Brychtova, M.D., Ph.D., Jana Smardova, Prof., Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Prof., Martin Trbusek, PhD
Journal: Blood
Blood (2012) 120 (21): 3902.
https://doi.org/10.1182/blood.V120.21.3902.3902
Published: 2012
Journal Articles

Mutational Analysis of TP53 Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches

Barbara Kantorova, MSc., Jitka Malcikova, Dr., PhD., Jana Kminkova, PharmD., Veronika Navrkalova, MSc., Barbora Dvorakova, MSc., Boris Tichy, Dr., PhD., Jana Smardova, Prof., Martin Trbusek, Dr., PhD., Sim Truong, PhD., Katerina Stano-Kozubik, PhD., Nikola Tom, MSc., Karol Pal, MSc., Ludmila Sebejova, Dr., Nancy Patten, PhD., Lin Wu, PhD., Michael Doubek, M.D., PhD., Prof., Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Dr., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 3911.
https://doi.org/10.1182/blood.V120.21.3911.3911
Published: 2012
Journal Articles

Multivariate and Subgroup Analyses of a Multinational Phase III Trial of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Jiri Mayer, M.D., PhD., Prof., Christopher Arthur, MD, Jacques Delaunay, MD, Grzegorz Mazur, MD, PhD, Xavier Thomas, MD, Agnieszka Wierzbowska, MD, PhD, Mark M Jones, MD, Erhan Berrak, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2012) 120 (21): 3618.
https://doi.org/10.1182/blood.V120.21.3618.3618
Published: 2012
Journal Articles

Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts

Markus Pfirrmann, Susanne Saussele, Andreas Hochhaus, MD, Andreas Reiter, MD, Ute Berger, Dieter K. Hossfeld, Christoph Nerl, Christof Scheid, Karsten Spiekermann, Jiri Mayer, M.D., PhD., Prof., Christiane Falge, Herbert G. Sayer, Donald Bunjes, Arnold Ganser, Dietrich W. Beelen, Helen Baldomero, Urs Schanz, Hermann Heimpel, Joerg Hasford, Hans-Jochem Kolb, Alois Gratwohl, Rüdiger Hehlmann, The German CML Study Group
Journal: Blood
Blood (2012) 120 (21): 3748.
https://doi.org/10.1182/blood.V120.21.3748.3748
Published: 2012
Journal Articles

Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 M utations to Chemotherapy.

Jana Zemanova, Ludmila Sebejova, Dr., Ondrej Hylse, Kamil Paruch, Ph.D., Sarka Pavlova, Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Dr., PhD, Prof., Martin Trbusek, Dr., PhD.
Journal: Blood
Blood (2012) 120 (21): 2460.
https://doi.org/10.1182/blood.V120.21.2460.2460
Published: 2012
Journal Articles

Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Prognostic Significance of Complete Response.

Marta Krejci, MD, PhD, Roman Hajek, Prof. MD, PhD, Zdenek Adam, Prof. MD, PhD, Ludek Pour, MD, PhD, Lenka Zahradova, MD, PhD, Jana Pelcova, Jiri Mayer, M.D., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 3126.
https://doi.org/10.1182/blood.V120.21.3126.3126
Published: 2012
Journal Articles

Outcome of Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated with or without Rituximab

Heidi Mocikova, MD, PhD, Jozef Michalka, MD, Jan Koren, Pavla Stepankova, Alexander Wild, Ludek Raida, MD, Jana Markova, MD, Zdenek Kral, Marek Trneny, MD, Karel Indrak, MD, Prof., Jiri Mayer, M.D., PhD., Prof., Tomas Kozak, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 4878.
https://doi.org/10.1182/blood.V120.21.4878.4878
Published: 2012